Donald Calne Lecture 2017
Please join us for the 13th Donald Calne Lecture
Date: Sunday, June 4, 2017
Time: 12:45 p.m. - 2:30 p.m.
Location: Vancouver Convention Centre, East Building - Meeting Room 11,
999 Canada Place, Vancouver, British Columbia
The Donald Calne Lecture is an exclusive event presented in conjunction with the 21st International Parkinson’s Disease and Movement Disorders Congress and requires separate registration through Parkinson Canada.
Presenter: Dr. Andrew Lees
Dr. Andrew Lees is a professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square, London and University College London. In 2011 he was named as the world’s most highly cited Parkinson’s disease researcher with over 23,000 citations since 1985.
Dr. Lees was responsible for the introduction of the use of apomorphine to treat advanced complications of Parkinson’s disease including dyskinesias and complications of the use of levodopa. In 2006 Dr. Lees received the American Academy of Neurology Movement Disorders Life Time Achievement Award for his outstanding achievements in the field of Parkinson’s disease and other movement disorders. In 2012 he was awarded the Dingebauer Prize by the German Society of Neurology for his outstanding achievement in the field of Movement Disorders.
- Advance registration and onsite check-in are required as seating is limited.
- Lunch buffet at 12:45 p.m.
- Lecture starts promptly at 1:30 p.m.
- This invitation is non-transferable.
- Register online (click the button below) by May 26, 2017 or email Lee.Nichols@parkinson.ca or call 1-800-565-3000, ext. 3378.
About the Donald Calne Lecture
Finding better ways to detect, diagnose, treat and ultimately, cure Parkinson’s requires cooperation from a global scientific community. The Donald Calne Lectureship, established in Canada in 2002, honours research that makes an impact on the world stage. Each year, the award celebrates a distinguished neuroscientist whose research is helping us learn more about how to prevent, diagnose, and treat Parkinson’s. The recipient gives a speech, on the state of Parkinson’s research, to Canadian scientists, medical professionals, people with Parkinson’s and their families.